Report

Global Human Insulin Drugs and Delivery Devices Market Size study, by Drug Type, by Device Type and Regional Forecasts 2022-2028

  • Publish Date: Oct,2022
  • Report ID: QI037
  • Page : 200
  • Report Type : PDF (Email)
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Human Insulin Drugs and Delivery Devices Market, by region, 2020-2028 (USD Billion)
1.2.2. Human Insulin Drugs and Delivery Devices Market, by Drug Type, 2020-2028 (USD Billion)
1.2.3. Human Insulin Drugs and Delivery Devices Market, by Device Type, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Human Insulin Drugs and Delivery Devices Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Human Insulin Drugs and Delivery Devices Market Dynamics
3.1. Human Insulin Drugs and Delivery Devices Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Growth in the Number of Diabetic Patients
3.1.1.2. Rising Market Demand for HI Analogs
3.1.2. Market Challenges
3.1.2.1. Stringent Regulatory Requirements for Product Approval
3.1.3. Market Opportunities
3.1.3.1. Expected Patent Expiry of Key HI Drugs
3.1.3.2. Emerging Markets
Chapter 4. Global Human Insulin Drugs and Delivery Devices Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Human Insulin Drugs and Delivery Devices Market, by Drug Type
6.1. Market Snapshot
6.2. Global Human Insulin Drugs and Delivery Devices Market by Drug Type, Performance - Potential Analysis
6.3. Global Human Insulin Drugs and Delivery Devices Market Estimates & Forecasts by Drug Type, 2018-2028 (USD Billion)
6.4. Human Insulin Drugs and Delivery Devices Market, Sub Segment Analysis
6.4.1. Basal or Long-acting Insulins
6.4.2. Bolus or Fast-acting Insulins
6.4.3. Traditional Human Insulins
6.4.4. Combination Insulins
6.4.5. Biosimilar Insulins
Chapter 7. Global Human Insulin Drugs and Delivery Devices Market, by Device Type
7.1. Market Snapshot
7.2. Global Human Insulin Drugs and Delivery Devices Market by Device Type, Performance - Potential Analysis
7.3. Global Human Insulin Drugs and Delivery Devices Market Estimates & Forecasts by Device Type, 2018-2028 (USD Billion)
7.4. Human Insulin Drugs and Delivery Devices Market, Sub Segment Analysis
7.4.1. Insulin Pens
7.4.2. Insulin Pumps
7.4.3. Insulin Syringes
7.4.4. Jet Injectors
Chapter 8. Global Human Insulin Drugs and Delivery Devices Market, Regional Analysis
8.1. Human Insulin Drugs and Delivery Devices Market, Regional Market Snapshot
8.2. North America Human Insulin Drugs and Delivery Devices Market
8.2.1. U.S. Human Insulin Drugs and Delivery Devices Market
8.2.1.1. Drug Type breakdown estimates & forecasts, 2018-2028
8.2.1.2. Device Type breakdown estimates & forecasts, 2018-2028
8.2.2. Canada Human Insulin Drugs and Delivery Devices Market
8.3. Europe Human Insulin Drugs and Delivery Devices Market Snapshot
8.3.1. U.K. Human Insulin Drugs and Delivery Devices Market
8.3.2. Germany Human Insulin Drugs and Delivery Devices Market
8.3.3. France Human Insulin Drugs and Delivery Devices Market
8.3.4. Spain Human Insulin Drugs and Delivery Devices Market
8.3.5. Italy Human Insulin Drugs and Delivery Devices Market
8.3.6. Rest of Europe Human Insulin Drugs and Delivery Devices Market
8.4. Asia-Pacific Human Insulin Drugs and Delivery Devices Market Snapshot
8.4.1. China Human Insulin Drugs and Delivery Devices Market
8.4.2. India Human Insulin Drugs and Delivery Devices Market
8.4.3. Japan Human Insulin Drugs and Delivery Devices Market
8.4.4. Australia Human Insulin Drugs and Delivery Devices Market
8.4.5. South Korea Human Insulin Drugs and Delivery Devices Market
8.4.6. Rest of Asia Pacific Human Insulin Drugs and Delivery Devices Market
8.5. Latin America Human Insulin Drugs and Delivery Devices Market Snapshot
8.5.1. Brazil Human Insulin Drugs and Delivery Devices Market
8.5.2. Mexico Human Insulin Drugs and Delivery Devices Market
8.6. Rest of The World Human Insulin Drugs and Delivery Devices Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Sanofi Aventis
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Novo Nordisk A/S
9.2.3. Insulet
9.2.4. Eli Lilly
9.2.5. Exir
9.2.6. Biocon
9.2.7. Becton Dickinson
9.2.8. Medtronic
9.2.9. Ypsomed
9.2.10. Julphar
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption